Skip to main
PATH

UiPath (PATH) Stock Forecast & Price Target

UiPath (PATH) Analyst Ratings

Based on 14 analyst ratings
Hold
Strong Buy 14%
Buy 0%
Hold 79%
Sell 7%
Strong Sell 0%

Bulls say

UiPath is experiencing stabilizing demand trends, showing improving demand and execution in multiple metrics, including positive net new ARR growth on an organic, constant-currency basis and improving NRR. Additionally, the company's significant investments in AI technology, demonstrated through its recent acquisition of WorkFusion and strong performance in AI-related ARR, are positioning it for long-term success in the growing RPA market. Furthermore, UiPath's strong partnerships, robust sales execution, and disciplined approach to operational efficiency make it a solid choice for investors.

Bears say

UiPath is currently experiencing high demand for their agentic modules, which are being leveraged in 80% of their top deals in the quarter. This uptick in demand, along with growth in subscription and license revenue and a strong cash position, suggests continued growth potential for the company. However, management notes that the demand environment remains variable, and the company's guidance reflects this uncertainty. Additionally, while agentic testing remains a widely deployed offering and the company is seeing success in the life sciences and financial services industries, they also cite strength in Australia as a geographic market.

UiPath (PATH) has been analyzed by 14 analysts, with a consensus rating of Hold. 14% of analysts recommend a Strong Buy, 0% recommend Buy, 79% suggest Holding, 7% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of UiPath and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About UiPath (PATH) Forecast

Analysts have given UiPath (PATH) a Hold based on their latest research and market trends.

According to 14 analysts, UiPath (PATH) has a Hold consensus rating as of Aug 29, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $13.93, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $13.93, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

UiPath (PATH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.